Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 1
1990 1
1991 1
1993 1
1994 1
1995 1
1996 3
1998 2
1999 3
2000 3
2001 3
2002 2
2003 1
2004 3
2005 1
2006 1
2007 2
2009 1
2010 1
2011 5
2012 5
2013 2
2014 1
2015 3
2016 2
2017 5
2018 3
2019 6
2020 4
2021 6
2022 7
2023 2
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

74 results

Results by year

Filters applied: . Clear all
Page 1
Preface.
O'Bryan JP, Piazza GA. O'Bryan JP, et al. Adv Cancer Res. 2022;153:xiii-xiv. doi: 10.1016/S0065-230X(22)00012-4. Adv Cancer Res. 2022. PMID: 35101237 No abstract available.
Targeting the "undruggable" RAS with biologics.
Whaby M, Khan I, O'Bryan JP. Whaby M, et al. Among authors: o bryan jp. Adv Cancer Res. 2022;153:237-266. doi: 10.1016/bs.acr.2021.07.006. Epub 2021 Aug 13. Adv Cancer Res. 2022. PMID: 35101232 Free PMC article. Review.
Exploring switch II pocket conformation of KRAS(G12D) with mutant-selective monobody inhibitors.
Akkapeddi P, Hattori T, Khan I, Glasser E, Koide A, Ketavarapu G, Whaby M, Zuberi M, Teng KW, Lefler J, Maso L, Bang I, Ostrowski MC, O'Bryan JP, Koide S. Akkapeddi P, et al. Among authors: o bryan jp. Proc Natl Acad Sci U S A. 2023 Jul 11;120(28):e2302485120. doi: 10.1073/pnas.2302485120. Epub 2023 Jul 3. Proc Natl Acad Sci U S A. 2023. PMID: 37399416 Free PMC article.
Biology, pathology, and therapeutic targeting of RAS.
Rhett JM, Khan I, O'Bryan JP. Rhett JM, et al. Among authors: o bryan jp. Adv Cancer Res. 2020;148:69-146. doi: 10.1016/bs.acr.2020.05.002. Epub 2020 Jul 9. Adv Cancer Res. 2020. PMID: 32723567 Free PMC article. Review.
Inhibition of RAS: proven and potential vulnerabilities.
Zuberi M, Khan I, O'Bryan JP. Zuberi M, et al. Among authors: o bryan jp. Biochem Soc Trans. 2020 Oct 30;48(5):1831-1841. doi: 10.1042/BST20190023. Biochem Soc Trans. 2020. PMID: 32869838 Free PMC article. Review.
Bimolecular fluorescence complementation.
Wong KA, O'Bryan JP. Wong KA, et al. Among authors: o bryan jp. J Vis Exp. 2011 Apr 15;(50):2643. doi: 10.3791/2643. J Vis Exp. 2011. PMID: 21525844 Free PMC article.
Direct inhibition of RAS: Quest for the Holy Grail?
Spencer-Smith R, O'Bryan JP. Spencer-Smith R, et al. Among authors: o bryan jp. Semin Cancer Biol. 2019 Feb;54:138-148. doi: 10.1016/j.semcancer.2017.12.005. Epub 2017 Dec 14. Semin Cancer Biol. 2019. PMID: 29248537 Free PMC article. Review.
Probing RAS Function with Monobodies.
Khan I, O'Bryan JP. Khan I, et al. Among authors: o bryan jp. Methods Mol Biol. 2021;2262:281-302. doi: 10.1007/978-1-0716-1190-6_17. Methods Mol Biol. 2021. PMID: 33977484 Free PMC article.
Intersecting pathways in cell biology.
O'Bryan JP. O'Bryan JP. Sci Signal. 2010 Dec 14;3(152):re10. doi: 10.1126/scisignal.3152re10. Sci Signal. 2010. PMID: 21156937 Free PMC article. Review.
74 results